For the Inventor, By the Inventor

Enter assignee name

London, United Kingdom

Mina Therapeutics Limited

USPTO Granted Patents = 16

EPO Patents = 11

Forward Citations = 6

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Pål Sætrom (10 out of 10 patents)

Hans E Huber (4 out of 6 patents)

Markus Hossbach (3 out of 20 patents)

4. Monika Krampert (3 out of 5 patents)

5. David Blakey (3 out of 3 patents)

6. Jon Voutila (3 out of 3 patents)

7. Pal Saetrom (2 out of 6 patents)

8. Vikash Reebye (2 out of 2 patents)

9. Hans-Peter Vornlocher (1 out of 53 patents)

10. Andreas Wagner (1 out of 1 patent)

11. Robert Habib (1 out of 1 patent)

12. Endre Bakken Stovner (1 out of 1 patent)

13. Siv Anita Hegre (1 out of 1 patent)

14. Pinelopi Andrikakou (1 out of 1 patent)

15. Pal Saertrom (0 patent)

16 patents: Sort by Forward Citations

1. 11965163 - HNF4a saRNA compositions and methods of use (2024-04-23),

2. 11566246 - SIRT1-saRNA compositions and methods of use (2023-01-31),

3. 11447773 - Stabilized HNF4A saRNA compositions and methods of use (2022-09-20),

4. 11365414 - Methods of inducing insulin production (2022-06-21),

5. 11162099 - HNF4A saRNA compositions and methods of use (2021-11-02),

6. 10912790 - C/EBP alpha saRNA compositions and methods of use (2021-02-09),

7. 10774331 - Methods of inducing insulin production (2020-09-15),

8. 10704044 - Albumin production and cell proliferation (2020-07-07),

9. 10633659 - C/EBPα short activating RNA compositions and methods of use (2020-04-28),

10. 10202601 - C/EBPα short activating RNA compositions and methods of use (2019-02-12),

11. 9944930 - Albumin production and cell proliferation (2018-04-17),

12. 9885046 - Methods of inducing insulin production (2018-02-06),

13. 9745579 - Albumin production and cell proliferation (2017-08-29),

14. 9284553 - Albumin production and cell proliferation (2016-03-15),

15. 8916534 - Methods of inducing insulin production (2014-12-23),

MINA Therapeutics Limited is a biotech company specializing in RNA-based therapies. The company focuses on developing innovative treatments for various diseases using its proprietary RNA activation platform. MINA Therapeutics aims to revolutionize the field of genetic medicine by unlocking the potential of RNA-based therapeutics to provide personalized and targeted treatments. For more information, please visit our website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

16 Patents

#190 in London

#1,100 in United Kingdom

#36,651 in the World

London, United Kingdom

Mina Therapeutics Limited

Forward Citations = 6

14 inventors:

Pål Sætrom (10 out of 10 patents)

Hans E Huber (4 out of 6 patents)

Markus Hossbach (3 out of 20 patents)

4. Monika Krampert (3 out of 5 patents)

5. David Blakey (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…